An Analysis of Recurrent Costs of the Free ART Programme of the Government of India
The potential accessibility of Antiretroviral (ARV) drugs at reduced cost and the emergence of largescale Antiretroviral Treatment (ART) programs in other developing countries, have spurred India to launch its own free antivretroviral treatment (A...
| Main Authors: | , , |
|---|---|
| Language: | English en_US |
| Published: |
World Bank, Washington, DC
2014
|
| Subjects: | |
| Online Access: | http://documents.worldbank.org/curated/en/2006/07/7228760/analysis-recurrent-costs-free-art-programme-government-india http://hdl.handle.net/10986/17822 |
| Summary: | The potential accessibility of
Antiretroviral (ARV) drugs at reduced cost and the emergence
of largescale Antiretroviral Treatment (ART) programs in
other developing countries, have spurred India to launch its
own free antivretroviral treatment (ART) program in April
2004. While many countries worldwide have attempted costing
of their national program on ART, India did not have any
economic or financial estimates of how much it actually
costs to run the free ART program, if all sources of
spending are included. This study was undertaken with the
aim of coming up with preliminary estimates of the recurrent
financial cost of the ART program. |
|---|